Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
Theofanis Economopoulos, Efstathios Papageorgiou, Nicholas Stathakis, Maria Constantinidou, Agapi Parharidou, Akrivi Kostourou, John Dervenoulas, Sotos RaptisVolume:
20
Year:
1996
Language:
english
Pages:
6
DOI:
10.1016/0145-2126(95)00169-7
File:
PDF, 605 KB
english, 1996